GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qingdao Vland Biotech Co Ltd (SHSE:603739) » Definitions » PEG Ratio

Qingdao Vland Biotech Co (SHSE:603739) PEG Ratio : N/A (As of Jun. 08, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Vland Biotech Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Qingdao Vland Biotech Co's PE Ratio without NRI is 36.44. Qingdao Vland Biotech Co's 5-Year EBITDA growth rate is -0.80%. Therefore, Qingdao Vland Biotech Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Qingdao Vland Biotech Co's PEG Ratio or its related term are showing as below:


During the past 10 years, Qingdao Vland Biotech Co's highest PEG Ratio was 32.11. The lowest was 27.23. And the median was 30.18.


SHSE:603739's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.52
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Qingdao Vland Biotech Co PEG Ratio Historical Data

The historical data trend for Qingdao Vland Biotech Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Vland Biotech Co PEG Ratio Chart

Qingdao Vland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.20 - - - -

Qingdao Vland Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Qingdao Vland Biotech Co's PEG Ratio

For the Biotechnology subindustry, Qingdao Vland Biotech Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qingdao Vland Biotech Co's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qingdao Vland Biotech Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Qingdao Vland Biotech Co's PEG Ratio falls into.



Qingdao Vland Biotech Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Qingdao Vland Biotech Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=36.44385026738/-0.80
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Qingdao Vland Biotech Co  (SHSE:603739) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Qingdao Vland Biotech Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Qingdao Vland Biotech Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao Vland Biotech Co (SHSE:603739) Business Description

Traded in Other Exchanges
N/A
Address
No. 1318, Wangsha Road, Room 108, Enterprise Service Center, Chengyang District, Shandong, Qingdao, CHN, 266061
Qingdao Vland Biotech Co Ltd is a biotechnology company. The company is engaged in research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Executives
Chen Gang Director
Jia De Qiang Director
Cao Cheng Director
Jiang Yong senior management
Xu Yong Supervisors

Qingdao Vland Biotech Co (SHSE:603739) Headlines

No Headlines